top of page
Peary Spaght.jpg

John Fletcher

Managing Partner Emeritus

John founded Fletcher Spaght in 1983. He remains active with FSI with analytical insights and creative solutions derived from his years of experience with clients, portfolio companies and the investment community. John has particular interests in devices, specifically in cardiology, cardiac surgery, and orthopedics, as well as in biopharma and healthcare IT.


Prior to founding Fletcher Spaght, John was a Senior Manager at The Boston Consulting Group, advising a broad range of companies in healthcare and high technology industries.


John currently serves as the Chairman of ClearPoint Neuro, Koru Medical, Vyant Bio, and Metabolon. Previously, he served as Chairman of Spectranetics during its turnaround and subsequent sale to Philips N,V,; for this work, he was selected as Director of the Year by the National Association of Corporate Directors. He is Chairman Emeritus of the Corporate Collaboration Council at the Thayer School of Engineering/Tuck School of Business at Dartmouth College and serves on the Board of Advisors of Beth Israel Deaconess Medical Center and the Whitehead Institute at MIT.


John received his MBA from Southern Illinois University and a BBA in Marketing from George Washington University. He was an Instructor for courses in international business and a PhD Candidate at the Wharton School of the University of Pennsylvania. He served as a Captain and jet pilot in the U.S. Air Force and continues to be active in aviation.

bottom of page